Petronek M, Stolwijk J, Murray S, Steinbach E, Zakharia Y, Buettner G
Redox Biol. 2021; 42:101864.
PMID: 33485837
PMC: 8113052.
DOI: 10.1016/j.redox.2021.101864.
Ray A, Chitre N, Daphney C, Blough B, Canal C, Murnane K
Psychopharmacology (Berl). 2018; 236(3):1107-1117.
PMID: 30276421
PMC: 6443494.
DOI: 10.1007/s00213-018-5044-z.
Dang D, Shin E, Kim D, Tran H, Jeong J, Jang C
J Neuroinflammation. 2018; 15(1):52.
PMID: 29467000
PMC: 5822489.
DOI: 10.1186/s12974-018-1087-7.
Sanchez A, Kaul M
Brain Sci. 2017; 7(3).
PMID: 28241493
PMC: 5366824.
DOI: 10.3390/brainsci7030025.
Althobaiti Y, Alshehri F, Almalki A, Sari Y
Front Neurosci. 2016; 10:427.
PMID: 27713684
PMC: 5031687.
DOI: 10.3389/fnins.2016.00427.
The Role of Oxidative Stress in Methamphetamine-induced Toxicity and Sources of Variation in the Design of Animal Studies.
McDonnell-Dowling K, Kelly J
Curr Neuropharmacol. 2016; 15(2):300-314.
PMID: 27121285
PMC: 5412700.
DOI: 10.2174/1570159x14666160428110329.
HIV-1, methamphetamine and astrocytes at neuroinflammatory Crossroads.
Borgmann K, Ghorpade A
Front Microbiol. 2015; 6:1143.
PMID: 26579077
PMC: 4621459.
DOI: 10.3389/fmicb.2015.01143.
The cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disorders.
Mediouni S, Marcondes M, Miller C, McLaughlin J, Valente S
Front Microbiol. 2015; 6:1164.
PMID: 26557111
PMC: 4615951.
DOI: 10.3389/fmicb.2015.01164.
Methamphetamine effects on blood-brain barrier structure and function.
Northrop N, Yamamoto B
Front Neurosci. 2015; 9:69.
PMID: 25788874
PMC: 4349189.
DOI: 10.3389/fnins.2015.00069.
Ginsenoside Re rescues methamphetamine-induced oxidative damage, mitochondrial dysfunction, microglial activation, and dopaminergic degeneration by inhibiting the protein kinase Cδ gene.
Shin E, Shin S, Nguyen T, Park D, Wie M, Jang C
Mol Neurobiol. 2014; 49(3):1400-21.
PMID: 24430743
DOI: 10.1007/s12035-013-8617-1.
Pharmacological evaluation of SN79, a sigma (σ) receptor ligand, against methamphetamine-induced neurotoxicity in vivo.
Kaushal N, Seminerio M, Robson M, McCurdy C, Matsumoto R
Eur Neuropsychopharmacol. 2012; 23(8):960-71.
PMID: 22921523
PMC: 3748261.
DOI: 10.1016/j.euroneuro.2012.08.005.
Effects of exposure to amphetamine derivatives on passive avoidance performance and the central levels of monoamines and their metabolites in mice: correlations between behavior and neurochemistry.
Murnane K, Perrine S, Finton B, Galloway M, Howell L, Fantegrossi W
Psychopharmacology (Berl). 2011; 220(3):495-508.
PMID: 21993877
PMC: 3289749.
DOI: 10.1007/s00213-011-2504-0.
Screening assay for oxidative stress in a feline astrocyte cell line, G355-5.
Testa M, Alvarado O, Wournell A, Lee J, Guilford F, Henriksen S
J Vis Exp. 2011; (53):e2841.
PMID: 21775965
PMC: 3196181.
DOI: 10.3791/2841.
Neurotoxins: free radical mechanisms and melatonin protection.
Reiter R, Manchester L, Tan D
Curr Neuropharmacol. 2011; 8(3):194-210.
PMID: 21358970
PMC: 3001213.
DOI: 10.2174/157015910792246236.
Regulation of glutamate release by α7 nicotinic receptors: differential role in methamphetamine-induced damage to dopaminergic and serotonergic terminals.
Northrop N, Smith L, Yamamoto B, Eyerman D
J Pharmacol Exp Ther. 2010; 336(3):900-7.
PMID: 21159748
PMC: 3061539.
DOI: 10.1124/jpet.110.177287.
Sigma (σ) receptor ligand, AC927 (N-phenethylpiperidine oxalate), attenuates methamphetamine-induced hyperthermia and serotonin damage in mice.
Seminerio M, Kaushal N, Shaikh J, Huber J, Coop A, Matsumoto R
Pharmacol Biochem Behav. 2010; 98(1):12-20.
PMID: 21130800
PMC: 3726056.
DOI: 10.1016/j.pbb.2010.11.023.
Neurotoxicity of methamphetamine and methylenedioxymethamphetamine.
Seiden L, Lew R, Malberg J
Neurotox Res. 2004; 3(1):101-16.
PMID: 15111264
DOI: 10.1007/BF03033233.
Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine.
LaVoie M, Hastings T
J Neurosci. 1999; 19(4):1484-91.
PMID: 9952424
PMC: 6786023.
Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") and its congeners.
Huether G, Zhou D, Ruther E
J Neural Transm (Vienna). 1997; 104(8-9):771-94.
PMID: 9451711
DOI: 10.1007/BF01285547.
Molecular mechanism of the inactivation of tryptophan hydroxylase by nitric oxide: attack on critical sulfhydryls that spare the enzyme iron center.
Kuhn D, Arthur Jr R
J Neurosci. 1997; 17(19):7245-51.
PMID: 9295371
PMC: 6573465.